
|Videos|March 16, 2022
Real-world feedback on nasal spray DED treatment
Author(s)Carly Rose, OD, FAAO
Carly Rose, OD, FAAO, shares her experience and patient feedback on implementing the first and only FDA-approved nasal spray for dry eye treatment.
Advertisement
Carly Rose, OD, FAAO, in practice at Eyecare on the Square in Cincinnati, Ohio, shares her experience implementing varenicline solution nasal spray (TYRVAYA, Oyster Point Pharma), the first and only FDA-approved nasal spray for dry eye treatment, in her practice, as well as the promising patient feedback she's received.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
FDA approves Outlook Therapeutics' Lytenava for wet AMD
2
Frantz EyeCare reports high refractive accuracy with Light Adjustable Lens
3
Rethinking OCT biomarkers in DME: Baseline acuity and thickness outperform the rest
4
Bausch + Lomb launches EyeGility preloaded IOL delivery system in US
5
























